Retracted: Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Retracted: Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER ; volume:9 ; number:2 ; day:13 ; month:9 ; year:2012 ; pages:1 ; date:9.2012
Retrovirology ; 9, Heft 2 (13.9.2012), 1, 9.2012
- Urheber
-
Han, D.
- Beteiligte Personen und Organisationen
-
Habte, H.
Qin, Y.
Takamoto, K.
LaBranche, C.
Montefiori, D.
Cho, MW
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-9-S2-P362
- URN
-
urn:nbn:de:1111-2016080724526
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Han, D.
- Habte, H.
- Qin, Y.
- Takamoto, K.
- LaBranche, C.
- Montefiori, D.
- Cho, MW
- SpringerLink (Online service)
Ähnliche Objekte (12)
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Retraction Note: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
Broadly Neutralizing Antibodies for HIV Eradication
Eliciting neutralizing antibodies with gp120 outer domain
Eliciting CD4-mimicking broadly neutralizing antibodies: new avenues towards the rational design of an HIV vaccine
The expanding array of HIV broadly neutralizing antibodies
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
Design clues from functional constraints and broadly neutralizing antibodies
Identification and characterization of broadly neutralizing antibodies targeting viral infections
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Retraction Note: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
Broadly Neutralizing Antibodies for HIV Eradication
Eliciting neutralizing antibodies with gp120 outer domain
Eliciting CD4-mimicking broadly neutralizing antibodies: new avenues towards the rational design of an HIV vaccine
The expanding array of HIV broadly neutralizing antibodies
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
Design clues from functional constraints and broadly neutralizing antibodies
Identification and characterization of broadly neutralizing antibodies targeting viral infections
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Retraction Note: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
Broadly Neutralizing Antibodies for HIV Eradication
Eliciting neutralizing antibodies with gp120 outer domain
Eliciting CD4-mimicking broadly neutralizing antibodies: new avenues towards the rational design of an HIV vaccine
The expanding array of HIV broadly neutralizing antibodies
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
Design clues from functional constraints and broadly neutralizing antibodies
Identification and characterization of broadly neutralizing antibodies targeting viral infections
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Broadly neutralizing antibodies and vaccine design against HIV-1 infection